Article Versions Notes

Kito Y, Kachi K, Yoshida M, Hori Y, Kato A, Sahashi H, Toyohara T, Kuno K, Adachi A, Urakabe K, et al. Potential of Anti-Leukotriene Drugs as New Therapeutic Agents for Inhibiting Cholangiocarcinoma Progression. Molecules. 2024; 29(14):3379. https://doi.org/10.3390/molecules29143379

Kito, Yusuke, Kenta Kachi, Michihiro Yoshida, Yasuki Hori, Akihisa Kato, Hidenori Sahashi, Tadashi Toyohara, Kayoko Kuno, Akihisa Adachi, Kenji Urakabe, and et al. 2024. "Potential of Anti-Leukotriene Drugs as New Therapeutic Agents for Inhibiting Cholangiocarcinoma Progression" Molecules 29, no. 14: 3379. https://doi.org/10.3390/molecules29143379

Kito, Y., Kachi, K., Yoshida, M., Hori, Y., Kato, A., Sahashi, H., Toyohara, T., Kuno, K., Adachi, A., Urakabe, K., & Kataoka, H. (2024). Potential of Anti-Leukotriene Drugs as New Therapeutic Agents for Inhibiting Cholangiocarcinoma Progression. Molecules, 29(14), 3379. https://doi.org/10.3390/molecules29143379